Carapito, Raphael http://orcid.org/0000-0002-7036-442X
Aouadi, Ismail
Pichot, Angélique
Spinnhirny, Perrine
Morlon, Aurore
Kotova, Irina
Macquin, Cécile
Rolli, Véronique
Cesbron, Anne
Gagne, Katia
Oudshoorn, Machteld
van der Holt, Bronno
Labalette, Myriam
Spierings, Eric http://orcid.org/0000-0001-9441-1019
Picard, Christophe
Loiseau, Pascale
Tamouza, Ryad
Toubert, Antoine
Parissiadis, Anne
Dubois, Valérie
Paillard, Catherine
Maumy-Bertrand, Myriam
Bertrand, Frédéric
von dem Borne, Peter A.
Kuball, Jürgen H. E. http://orcid.org/0000-0002-3914-7806
Michallet, Mauricette
Lioure, Bruno
Peffault de Latour, Régis
Blaise, Didier http://orcid.org/0000-0002-5684-9447
Cornelissen, Jan J.
Yakoub-Agha, Ibrahim
Claas, Frans
Moreau, Philippe
Charron, Dominique
Mohty, Mohamad
Morishima, Yasuo
Socié, Gérard http://orcid.org/0000-0002-2114-7533
Bahram, Seiamak http://orcid.org/0000-0002-6928-9952
Funding for this research was provided by:
Institut National de la Santé et de la Recherche Médicale (U1109)
Institut Universitaire de France (Membre senior)
Agence Nationale de la Recherche (ANR-11-LABX-0070_TRANSPLANTEX)
EC | European Regional Development Fund (INTERREG V program - n°3.2 TRIDIAG)
Article History
Received: 17 December 2019
Revised: 17 March 2020
Accepted: 23 March 2020
First Online: 14 April 2020
Compliance with ethical standards
:
: SB is the scientific founder and a (minority) shareholder of BIOMICA SAS. JK is the co-founder and chief scientific officer of Gadeta. He received personal fees from Gadeta. In addition, JK has a patent issued/pending. ES is the inventor of a patent application filed by the University Medical Center Utrecht on the prediction of an alloimmune response against mismatched HLA (PCT/EPT2013/073386). All other authors declare no conflict of interests.